Macrocyclic peptides are designed to engage complex targets like biologics but pass through cell membranes like small ...

Healx, a pioneer in AI-powered drug discovery for rare and neglected conditions, has partnered with SCI Ventures - the world’s first specialist venture fund focused on curing paralysis- to accelerate ...

Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...

As Indian IT enters FY26, Indian IT giants have been announcing work on hundreds of AI agents and drug discovery. TCS, Infosys, Wipro, and Tech Mahindra have all been partnering with AI startups for ...

Cancer persists as a leading cause of mortality worldwide, underscoring the urgent need to decipher its molecular complexity for improved detection, ...

Scientists at Shaanxi Normal University have developed an AI-powered dual-channel model that predicts miRNA–drug interactions with up to 96% ...

AI’s perfection cannot capture the imperfections of the human mind -- which touches our souls differently by creating nuanced ...

XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced ...

Discover 7 college majors designed to help students thrive in an AI-driven economy—build skills in leadership, innovation, ...

ResearchAndMarkets projects the AI medical diagnostics market to surge to $46.59 billion by 2034, driven by a blistering 33.72% CAGR. Private equity firms believe 2025 could eclipse 2024 as the ...

XtalPi has accrued a number of Big Pharma partners over the years, including Eli Lilly, which struck a $250 million deal in 2023 to use XtalPi’s tech to identify potential drug candidates that Lilly ...